HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation.

AuthorsMaximilian Jahns, Dorothea Friess, Franziska Demarmels Biasiutti, Johanna A Kremer Hovinga, Lorenzo Alberio, Johannes Oldenburg, Bernhard Lämmle, Giuseppe Colucci
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 106 Issue 2 Pg. 381-2 (Aug 2011) ISSN: 2567-689X [Electronic] Germany
PMID21655682 (Publication Type: Case Reports, Letter)
Chemical References
  • Anticoagulants
  • Protein Precursors
  • SERPINC1 protein, human
  • factor IX Cambridge
  • Vitamin K
  • Antithrombin III
  • Factor IX
  • Phenprocoumon
Topics
  • Adult
  • Anticoagulants (adverse effects)
  • Antithrombin III (genetics)
  • Antithrombin III Deficiency (complications, drug therapy, genetics)
  • Factor IX (genetics)
  • Hematoma (blood, etiology)
  • Humans
  • Male
  • Muscular Diseases (blood, etiology)
  • Mutation
  • Phenprocoumon (adverse effects)
  • Protein Precursors (genetics)
  • Venous Thrombosis (drug therapy, etiology)
  • Vitamin K (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: